Genetic determinants of dengue type 4 virus neurovirulence for mice
- PMID: 8411360
- PMCID: PMC238094
- DOI: 10.1128/JVI.67.11.6567-6575.1993
Genetic determinants of dengue type 4 virus neurovirulence for mice
Abstract
Mouse-adapted dengue type 4 virus (DEN4) strain H241 is highly neurovirulent for mice, whereas its non-mouse-adapted parent is rarely neurovirulent. The genetic basis for the neurovirulence of the mouse-adapted mutant was studied by comparing intratypic chimeric viruses that contained the three structural protein genes from the parental virus or the neurovirulent mutant in the background sequence of nonneurovirulent DEN4 strain 814669. The chimera that contained the three structural protein genes from mouse neurovirulent DEN4 strain H241 proved to be highly neurovirulent in mice, whereas the chimera that contained the corresponding genes from its non-mouse-adapted parent was not neurovirulent. This finding indicates that most of the genetic loci for the neurovirulence of the DEN4 mutant lie within the structural protein genes. A comparison of the amino acid sequences of the parent and its mouse neurovirulent mutant proteins revealed that there were only five amino acid differences in the structural protein region, and three of these were located in the envelope (E) glycoprotein. Analysis of chimeras which contained one or two of the variant amino acids of the mutant E sequence substituting for the corresponding sequence of the parental virus identified two of these amino acid changes as important determinants of mouse neurovirulence. First, the single substitution of Ile for Thr-155 which ablated one of the two conserved glycosylation sites in parental E yielded a virus that was almost as neurovirulent as the mouse-adapted mutant. Thus, the loss of an E glycosylation site appears to play a role in DEN4 neurovirulence. Second, the substitution of Leu for Phe-401 also yielded a neurovirulent virus, but it was less neurovirulent than the glycosylation mutant. These findings indicate that at least two of the genetic loci responsible for DEN4 mouse neurovirulence map within the structural protein genes.
Similar articles
-
Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence.J Virol. 1998 Feb;72(2):1647-51. doi: 10.1128/JVI.72.2.1647-1651.1998. J Virol. 1998. PMID: 9445071 Free PMC article.
-
Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice.J Virol. 1995 Aug;69(8):5186-90. doi: 10.1128/JVI.69.8.5186-5190.1995. J Virol. 1995. PMID: 7609092 Free PMC article.
-
Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice.J Virol. 1993 Aug;67(8):4956-63. doi: 10.1128/JVI.67.8.4956-4963.1993. J Virol. 1993. PMID: 8331735 Free PMC article.
-
Molecular Biology and Epidemiology of Neurotropic Viruses.Cureus. 2020 Aug 11;12(8):e9674. doi: 10.7759/cureus.9674. Cureus. 2020. PMID: 32923269 Free PMC article. Review.
-
Live Viral Vaccine Neurovirulence Screening: Current and Future Models.Vaccines (Basel). 2021 Jun 30;9(7):710. doi: 10.3390/vaccines9070710. Vaccines (Basel). 2021. PMID: 34209433 Free PMC article. Review.
Cited by
-
In vivo infection by a neuroinvasive neurovirulent dengue virus.J Neurovirol. 2012 Oct;18(5):374-87. doi: 10.1007/s13365-012-0117-y. Epub 2012 Jul 24. J Neurovirol. 2012. PMID: 22825914
-
Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.J Virol. 2005 Jun;79(12):7300-10. doi: 10.1128/JVI.79.12.7300-7310.2005. J Virol. 2005. PMID: 15919884 Free PMC article.
-
Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3.J Virol. 2000 Apr;74(7):3011-9. doi: 10.1128/jvi.74.7.3011-3019.2000. J Virol. 2000. PMID: 10708415 Free PMC article.
-
Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences.J Virol. 1994 Jul;68(7):4643-49. doi: 10.1128/JVI.68.7.4643-4649.1994. J Virol. 1994. PMID: 8207838 Free PMC article.
-
Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.Vaccine. 2010 Mar 24;28(15):2705-15. doi: 10.1016/j.vaccine.2010.01.022. Epub 2010 Jan 22. Vaccine. 2010. PMID: 20097152 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical